Related content

Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice

By Shizukuda Yukitaka   Matoba Satoaki   Mian Omar   Nguyen Tammy   Hwang Paul  

Molecular and Cellular Biochemistry, Vol. 273, Iss. 1-2, 2005-05 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Possible involvement of glutathione and p53 in trichloroethylene- and perchloroethylene-induced lipid peroxidation and apoptosis in human lung cancer cells

By Chen S.-J.   Wang J.-L.   Chen J.-H.   Huang R.-N.  

Free Radical Biology and Medicine, Vol. 33, Iss. 4, 2002-08 ,pp. : 464-472

Elsevier

Access to resources Recommend Favorite

Mitochondrial impairment in p53-deficient human cancer cells

By Zhou S.   Kachhap S.   Singh K.K.  

Mutagenesis, Vol. 18, Iss. 3, 2003-05 ,pp. : 287-292

Oxford University Press

Access to resources Recommend Favorite

p53 Inhibits Adriamycin-Induced Down-Regulation of Cyclin D1 Expression in Human Cancer Cells

By Shao J.   Teraishi F.   Katsuda K.   Tanaka N.   Fujiwara T.  

Biochemical and Biophysical Research Communications, Vol. 290, Iss. 3, 2002-01 ,pp. : 1101-1107

Elsevier

Access to resources Recommend Favorite

Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G

By Xu Xiaoyan   Liu Shuguang   Lei Bin   Li WenXia   Lin Ni   Sheng Wenjie   Huang Aili   Shen Hong  

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite